BANK OF AMERICA CORP /DE/ - ANI PHARMACEUTICALS INC ownership

ANI PHARMACEUTICALS INC's ticker is and the CUSIP is 00182CAA1. A total of 20 filers reported holding ANI PHARMACEUTICALS INC in Q2 2018. The put-call ratio across all filers is - and the average weighting 0.9%.

Quarter-by-quarter ownership
BANK OF AMERICA CORP /DE/ ownership history of ANI PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2018$1,000
-99.9%
500
-100.0%
0.00%
Q4 2017$1,831,0001,595,0000.00%
Other shareholders
ANI PHARMACEUTICALS INC shareholders Q2 2018
NameSharesValueWeighting ↓
Wellesley Asset Management 59,455$68,522,0003.54%
DLD Asset Management, LP 4,500,000$5,185,0001.70%
Worth Venture Partners, LLC 945,000$1,100,0001.18%
Perceptive Advisors 7,500,000$8,700,0000.62%
WOLVERINE ASSET MANAGEMENT LLC 15,439,000$17,789,0000.23%
Allianz Asset Management GmbH 35,165,000$40,795,0000.04%
GABELLI FUNDS LLC 1,500,000$1,740,0000.01%
AQR Arbitrage LLC 525,000$605,0000.01%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 9,000,000$10,328,0000.01%
Edge Advisors, LLC 33,000$38,0000.01%
View complete list of ANI PHARMACEUTICALS INC shareholders